Clinical significance of radiologic characterizations in COPD

Meilan K. Han, Brian Jack Bartholmai, Lyrica X. Liu, Susan Murray, Jeffrey L. Curtis, Frank C. Sciurba, Ella A. Kazerooni, Bruce Thompson, Margaret Frederick, Daner Li, Marvin Schwarz, Andrew Harold Limper, Christine Freeman, Rodney J. Landreneau, Robert Wise, Fernando J. Martinez

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

COPD is a heterogeneous disorder with clinical assessment becoming increasingly multidimensional. We hypothesized HRCT phenotype would strongly influence clinical outcomes including health status, exacerbation frequency, and BODE. COPD subjects were characterized via the SF-12, SGRQ, MMRC, physiologic testing, and standardized volumetric chest HRCT. Visual semi-quantitative estimation of bronchial wall thickness (VBT) and automated quantification of emphysema percent and bronchial wall thickness were generated. Multivariate modeling compared emphysema severity and airway abnormality with clinical outcome measures. Poisson models were used to analyze exacerbation frequency. SGRQ and SF-12 physical component scores were influenced by FEV1 predicted, emphysema percent, and VBT. VBT scores > 2 (scale 048) were associated with increased exacerbation frequency (p 0.009) in the preceding year adjusting for age, gender, emphysema percent, smoking history and FEV1 predicted, although this effect was attenuated by age. Emphysema percent correlated with total BODE score in unadjusted (r 0.73; p < 0.0001) and adjusted (p < 0.0001) analyses and with BODE individual components. HRCT provides unique COPD phenotyping information. Radiographic quantification of emphysema and bronchial thickness are independently associated with SGRQ and physical component score of the SF-12. Bronchial thickness but not emphysema is associated with exacerbation frequency, whereas emphysema is a stronger predictor of BODE and its systemic components MMRC, 6MWT, and BMI. Future research should clarify whether CT parameters complement BODE score in influencing survival.

Original languageEnglish (US)
Pages (from-to)459-467
Number of pages9
JournalCOPD: Journal of Chronic Obstructive Pulmonary Disease
Volume6
Issue number6
DOIs
StatePublished - 2009

Fingerprint

Emphysema
Chronic Obstructive Pulmonary Disease
Health Status
Thorax
Smoking
History
Outcome Assessment (Health Care)
Phenotype

Keywords

  • BODE
  • COPD
  • Exacerbation
  • HRCT
  • HRQL

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Clinical significance of radiologic characterizations in COPD. / Han, Meilan K.; Bartholmai, Brian Jack; Liu, Lyrica X.; Murray, Susan; Curtis, Jeffrey L.; Sciurba, Frank C.; Kazerooni, Ella A.; Thompson, Bruce; Frederick, Margaret; Li, Daner; Schwarz, Marvin; Limper, Andrew Harold; Freeman, Christine; Landreneau, Rodney J.; Wise, Robert; Martinez, Fernando J.

In: COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 6, No. 6, 2009, p. 459-467.

Research output: Contribution to journalArticle

Han, MK, Bartholmai, BJ, Liu, LX, Murray, S, Curtis, JL, Sciurba, FC, Kazerooni, EA, Thompson, B, Frederick, M, Li, D, Schwarz, M, Limper, AH, Freeman, C, Landreneau, RJ, Wise, R & Martinez, FJ 2009, 'Clinical significance of radiologic characterizations in COPD', COPD: Journal of Chronic Obstructive Pulmonary Disease, vol. 6, no. 6, pp. 459-467. https://doi.org/10.3109/15412550903341513
Han, Meilan K. ; Bartholmai, Brian Jack ; Liu, Lyrica X. ; Murray, Susan ; Curtis, Jeffrey L. ; Sciurba, Frank C. ; Kazerooni, Ella A. ; Thompson, Bruce ; Frederick, Margaret ; Li, Daner ; Schwarz, Marvin ; Limper, Andrew Harold ; Freeman, Christine ; Landreneau, Rodney J. ; Wise, Robert ; Martinez, Fernando J. / Clinical significance of radiologic characterizations in COPD. In: COPD: Journal of Chronic Obstructive Pulmonary Disease. 2009 ; Vol. 6, No. 6. pp. 459-467.
@article{f61a806a4d364730b8ff421a88fad017,
title = "Clinical significance of radiologic characterizations in COPD",
abstract = "COPD is a heterogeneous disorder with clinical assessment becoming increasingly multidimensional. We hypothesized HRCT phenotype would strongly influence clinical outcomes including health status, exacerbation frequency, and BODE. COPD subjects were characterized via the SF-12, SGRQ, MMRC, physiologic testing, and standardized volumetric chest HRCT. Visual semi-quantitative estimation of bronchial wall thickness (VBT) and automated quantification of emphysema percent and bronchial wall thickness were generated. Multivariate modeling compared emphysema severity and airway abnormality with clinical outcome measures. Poisson models were used to analyze exacerbation frequency. SGRQ and SF-12 physical component scores were influenced by FEV1 predicted, emphysema percent, and VBT. VBT scores > 2 (scale 048) were associated with increased exacerbation frequency (p 0.009) in the preceding year adjusting for age, gender, emphysema percent, smoking history and FEV1 predicted, although this effect was attenuated by age. Emphysema percent correlated with total BODE score in unadjusted (r 0.73; p < 0.0001) and adjusted (p < 0.0001) analyses and with BODE individual components. HRCT provides unique COPD phenotyping information. Radiographic quantification of emphysema and bronchial thickness are independently associated with SGRQ and physical component score of the SF-12. Bronchial thickness but not emphysema is associated with exacerbation frequency, whereas emphysema is a stronger predictor of BODE and its systemic components MMRC, 6MWT, and BMI. Future research should clarify whether CT parameters complement BODE score in influencing survival.",
keywords = "BODE, COPD, Exacerbation, HRCT, HRQL",
author = "Han, {Meilan K.} and Bartholmai, {Brian Jack} and Liu, {Lyrica X.} and Susan Murray and Curtis, {Jeffrey L.} and Sciurba, {Frank C.} and Kazerooni, {Ella A.} and Bruce Thompson and Margaret Frederick and Daner Li and Marvin Schwarz and Limper, {Andrew Harold} and Christine Freeman and Landreneau, {Rodney J.} and Robert Wise and Martinez, {Fernando J.}",
year = "2009",
doi = "10.3109/15412550903341513",
language = "English (US)",
volume = "6",
pages = "459--467",
journal = "COPD: Journal of Chronic Obstructive Pulmonary Disease",
issn = "1541-2555",
publisher = "Informa Healthcare",
number = "6",

}

TY - JOUR

T1 - Clinical significance of radiologic characterizations in COPD

AU - Han, Meilan K.

AU - Bartholmai, Brian Jack

AU - Liu, Lyrica X.

AU - Murray, Susan

AU - Curtis, Jeffrey L.

AU - Sciurba, Frank C.

AU - Kazerooni, Ella A.

AU - Thompson, Bruce

AU - Frederick, Margaret

AU - Li, Daner

AU - Schwarz, Marvin

AU - Limper, Andrew Harold

AU - Freeman, Christine

AU - Landreneau, Rodney J.

AU - Wise, Robert

AU - Martinez, Fernando J.

PY - 2009

Y1 - 2009

N2 - COPD is a heterogeneous disorder with clinical assessment becoming increasingly multidimensional. We hypothesized HRCT phenotype would strongly influence clinical outcomes including health status, exacerbation frequency, and BODE. COPD subjects were characterized via the SF-12, SGRQ, MMRC, physiologic testing, and standardized volumetric chest HRCT. Visual semi-quantitative estimation of bronchial wall thickness (VBT) and automated quantification of emphysema percent and bronchial wall thickness were generated. Multivariate modeling compared emphysema severity and airway abnormality with clinical outcome measures. Poisson models were used to analyze exacerbation frequency. SGRQ and SF-12 physical component scores were influenced by FEV1 predicted, emphysema percent, and VBT. VBT scores > 2 (scale 048) were associated with increased exacerbation frequency (p 0.009) in the preceding year adjusting for age, gender, emphysema percent, smoking history and FEV1 predicted, although this effect was attenuated by age. Emphysema percent correlated with total BODE score in unadjusted (r 0.73; p < 0.0001) and adjusted (p < 0.0001) analyses and with BODE individual components. HRCT provides unique COPD phenotyping information. Radiographic quantification of emphysema and bronchial thickness are independently associated with SGRQ and physical component score of the SF-12. Bronchial thickness but not emphysema is associated with exacerbation frequency, whereas emphysema is a stronger predictor of BODE and its systemic components MMRC, 6MWT, and BMI. Future research should clarify whether CT parameters complement BODE score in influencing survival.

AB - COPD is a heterogeneous disorder with clinical assessment becoming increasingly multidimensional. We hypothesized HRCT phenotype would strongly influence clinical outcomes including health status, exacerbation frequency, and BODE. COPD subjects were characterized via the SF-12, SGRQ, MMRC, physiologic testing, and standardized volumetric chest HRCT. Visual semi-quantitative estimation of bronchial wall thickness (VBT) and automated quantification of emphysema percent and bronchial wall thickness were generated. Multivariate modeling compared emphysema severity and airway abnormality with clinical outcome measures. Poisson models were used to analyze exacerbation frequency. SGRQ and SF-12 physical component scores were influenced by FEV1 predicted, emphysema percent, and VBT. VBT scores > 2 (scale 048) were associated with increased exacerbation frequency (p 0.009) in the preceding year adjusting for age, gender, emphysema percent, smoking history and FEV1 predicted, although this effect was attenuated by age. Emphysema percent correlated with total BODE score in unadjusted (r 0.73; p < 0.0001) and adjusted (p < 0.0001) analyses and with BODE individual components. HRCT provides unique COPD phenotyping information. Radiographic quantification of emphysema and bronchial thickness are independently associated with SGRQ and physical component score of the SF-12. Bronchial thickness but not emphysema is associated with exacerbation frequency, whereas emphysema is a stronger predictor of BODE and its systemic components MMRC, 6MWT, and BMI. Future research should clarify whether CT parameters complement BODE score in influencing survival.

KW - BODE

KW - COPD

KW - Exacerbation

KW - HRCT

KW - HRQL

UR - http://www.scopus.com/inward/record.url?scp=73549088517&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73549088517&partnerID=8YFLogxK

U2 - 10.3109/15412550903341513

DO - 10.3109/15412550903341513

M3 - Article

C2 - 19938970

AN - SCOPUS:73549088517

VL - 6

SP - 459

EP - 467

JO - COPD: Journal of Chronic Obstructive Pulmonary Disease

JF - COPD: Journal of Chronic Obstructive Pulmonary Disease

SN - 1541-2555

IS - 6

ER -